These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 9339201)

  • 21. Hydrocarbon carcinogens evade cellular defense mechanism of G1 arrest in nontransformed and malignant lung cell lines.
    Khan QA; Anderson LM
    Toxicol Appl Pharmacol; 2001 Jun; 173(2):105-13. PubMed ID: 11384212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell cycle control and cancer chemotherapy.
    Kohn KW; Jackman J; O'Connor PM
    J Cell Biochem; 1994 Apr; 54(4):440-52. PubMed ID: 8014193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells.
    Chang FL; Ling YF; Lai MD
    Anticancer Res; 2000; 20(1A):329-36. PubMed ID: 10769676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 mutations in epithelial ovarian cancers: possible role in predicting chemoresistance.
    Laframboise S; Chapman W; McLaughlin J; Andrulis IL
    Cancer J; 2000; 6(5):302-8. PubMed ID: 11079169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutant p53: the loaded gun.
    Selivanova G
    Curr Opin Investig Drugs; 2001 Aug; 2(8):1136-41. PubMed ID: 11892926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apoptosis and growth arrest induced by platinum compounds in U2-OS cells reflect a specific DNA damage recognition associated with a different p53-mediated response.
    Gatti L; Supino R; Perego P; Pavesi R; Caserini C; Carenini N; Righetti SC; Zuco V; Zunino F
    Cell Death Differ; 2002 Dec; 9(12):1352-9. PubMed ID: 12478472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin.
    Lin X; Ramamurthi K; Mishima M; Kondo A; Christen RD; Howell SB
    Cancer Res; 2001 Feb; 61(4):1508-16. PubMed ID: 11245458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncogenic mutation of the p53 gene derived from head and neck cancer prevents cells from undergoing apoptosis after DNA damage.
    Kawamata H; Omotehara F; Nakashiro K; Uchida D; Shinagawa Y; Tachibana M; Imai Y; Fujimori T
    Int J Oncol; 2007 May; 30(5):1089-97. PubMed ID: 17390010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Checking on the cell cycle.
    Mercer WE
    J Cell Biochem Suppl; 1998; 30-31():50-4. PubMed ID: 9893255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [TP53 tumor suppressor gene: 20 years (and ten thousand mutations) later].
    Hainaut P
    Bull Cancer; 2000 Jan; 87(1):11-8. PubMed ID: 10673626
    [No Abstract]   [Full Text] [Related]  

  • 31. The genetics of the p53 pathway, apoptosis and cancer therapy.
    Vazquez A; Bond EE; Levine AJ; Bond GL
    Nat Rev Drug Discov; 2008 Dec; 7(12):979-87. PubMed ID: 19043449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genes causing inherited cancer as beacons to identify the mechanisms of chemoresistance.
    Lønning PE
    Trends Mol Med; 2004 Mar; 10(3):113-8. PubMed ID: 15102353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated mutagenesis and decreased DNA repair at a transgene are associated with proliferation but not apoptosis in p53-deficient cells.
    Bielas JH; Heddle JA
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12853-8. PubMed ID: 14569010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells.
    Baptiste N; Friedlander P; Chen X; Prives C
    Oncogene; 2002 Jan; 21(1):9-21. PubMed ID: 11791172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The p53 gene and protein in 2005: new results, promising opportunities].
    Szoke D; Sipos F; Spisák S; Molnár B; Tulassay Z
    Orv Hetil; 2005 Jul; 146(30):1587-94. PubMed ID: 16136736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Restoration of wild-type p53 function in human tumors: strategies for efficient cancer therapy.
    Wiman KG
    Adv Cancer Res; 2007; 97():321-38. PubMed ID: 17419952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 expression overcomes p21WAF1/CIP1-mediated G1 arrest and induces apoptosis in human cancer cells.
    Kagawa S; Fujiwara T; Hizuta A; Yasuda T; Zhang WW; Roth JA; Tanaka N
    Oncogene; 1997 Oct; 15(16):1903-9. PubMed ID: 9365236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of different mutant p53 transgenes in neuroblastoma cells leads to different cellular responses to genotoxic agents.
    Gangopadhyay S; Jalali F; Reda D; Peacock J; Bristow RG; Benchimol S
    Exp Cell Res; 2002 Apr; 275(1):122-31. PubMed ID: 11925110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer. DNA damage, deamidation, and death.
    Li C; Thompson CB
    Science; 2002 Nov; 298(5597):1346-7. PubMed ID: 12434041
    [No Abstract]   [Full Text] [Related]  

  • 40. Enhanced sensitivity to anti-benzo(a)pyrene-diol-epoxide DNA damage correlates with decreased global genomic repair attributable to abrogated p53 function in human cells.
    Wani MA; Zhu Q; El-Mahdy M; Venkatachalam S; Wani AA
    Cancer Res; 2000 Apr; 60(8):2273-80. PubMed ID: 10786695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.